Malnutrition is state of nutrition in which a deficiency of energy, protein, and other nutrients causes adverse effects on the body's size, composition and function resulting in poorer clinical outcomes.3
Patients with GI disorders can present with several symptoms such as diarrhoea, bloating, abdominal pain and vomiting6.
If symptoms are improperly managed, this may lead to:
Nutritional support is vital for patients with GI disorders, as emphasised in several ESPEN guidelines.4,5
Tolerance to formulations containing whole protein and fats is often poor in patients with GI disorders.6,7
In patients with GI disorders, when absorption and digestion of nutrients is impaired, peptide-based feeds have been shown to improve tolerance.6,7
Designed to improve GI tolerance and increase nutritional intake in patients with impaired GI function.
Patient compliance to Peptisip Energy HP was 18% higher than with the prescribed baseline* ONS7. Increased compliance led to improved nutritional intake:7
† A p-value of ≤0.05 is statistically significant.
Peptisip Energy HP has been studied7 in a variety of patients with complex conditions requiring a peptide-based ONS. Results from four of these patients have been collated in a series of clinical case studies, which are presented in this booklet. The case studies are intended to help educate healthcare professionals about the role of Peptisip Energy HP and offer practical guidance on its use in managing patients with GI intolerance symptoms.
± Product can be provided to patients upon the request of a healthcare professional. They are intended for the purpose of professional evaluation only
Please ensure your role and areas of interest are up to date.